Updates
-
-
MS News that Caught My Eye Last Week: New Baclofen Pump, Bone Marrow Transplant Study, Bladder Problems and Life Quality, Urinary Diversion Surgery
Flowonix’s Prometra II Pump System Receives FDA Approval for Use with Intrathecal Baclofen This new pump could be a major step forward for ... Read more -
MS Patients Switching from Tysabri to Other Therapies May Risk Disease Activity
Multiple sclerosis (MS) patients switching from Tysabri (natalizumab) to other disease-modifying therapies may have an increased risk of disease activity, though the ... Read more -
Masitinib Slows Disability Progression in PPMS and Non-active SPMS, Phase 2/3 Trial Reports
AB Science‘s masitinib significantly slowed disability progression in people with primary progressive multiple sclerosis (PPMS) and non-active secondary progressive MS (SPMS) at ... Read more -
Thinking Outside the Box
There’s a story I love to tell about my dad, a retail warrior with more than 30 years of experience under his belt. And ... Read more -
Myeliviz Brings Hope for Faster MS Diagnosis
Myeliviz is the name of a new compound approved for a clinical trial in the U.S. that has the potential to make the process ... Read more
-
What can changes in grey matter mean for MS?
Sponsored Post
The brain is made up of two types of tissue: grey matter and white ... -
Spanish Modified Story Memory Technique Improves Cognitive Performance in Mexican Patients with MS, Study Says
The Spanish version of the modified Story Memory Technique improves learning and life satisfaction ... -
Flowonix’s Prometra II Pump System Receives FDA Approval for Use with Intrathecal Baclofen
The U.S. Food and Drug Administration (FDA) has granted approval to Flowonix Medical’s Prometra ... -
Need to Know: Is a Support Animal for MS Right for You?
Editor’s note: “Need to Know” is a series inspired by common forum questions and ... -
Finding My Way Through Sickness and Sadness with SPMS
I am hyperaware of the fragility of life. More specifically, the fragility of mine. ... -
#ACTRIMS2020 – Keynote Speaker Peter Calabresi to Discuss Link Between Genetics and MS Severity
Specific mutations in genes that provide instructions to make two proteins — called C3 ...
Subscribe to our mailing list
Get regular updates delivered to your email box.
Thanks! Please check your email for a confirmation email.
1st Patient Enrolled in Study of Electrical Stimulation in Treating Brain Injury
News
A first patient has been enrolled in a single-site trial to evaluate the potential of electrical stimulation, called Electroceutical Therapy, in reducing brain injury, Endonovo Therapeutics, the therapy’s developer, announced. Electroceutical Therapy is a non-invasive and wearable electronic device that uses pulsed ... Read more